| |DECEMBER 20244The Indian Pharmaceutical Intellectual Property Rights (IPR) consulting market is seeing huge growth due to the growing pharmaceutical industry and the increasing importance of intellectual property (IP) protection. India's pharmaceutical industry is undergoing rapid change, and is a leading global force in healthcare, particularly through generic drug production, but is increasingly affected by patent laws, innovation, and access to cost effective medicines. As companies navigate complex patent regulations, in particular following India's obligations under the World Trade Organization's TRIPS agreement, pharma IPR consultants in India are in demand. The IPR landscape in the country has a dynamic balance between the need for innovation and the broader public health goals such as provision of affordable medicines. Many of the consultants that provide expertise in patenting, trademarking and protecting proprietary drug formulations advise on strategies for overcoming challenges such as patent evergreening, which some pharmaceutical firms use to extend patent protections on already marketed drugs. Secondly, India's generic drug growth has led to demand for services that ensure compliance with local patent laws and help avoid infringement problems. India's compulsory licensing provisions also insist that pharmaceutical firms know when and how such licenses may be issued. This has resulted in more contact with IPR consultants, who provide information about patent filing strategies and the legal way to defend against counterfeit products. The market for IPR consulting in the pharmaceutical sector in India will grow further as companies will be looking to protect their innovations, comply with regulatory requirements and keep a competitive edge in both domestic and international markets. The trend is also likely to grow with the global integration of the Indian pharmaceutical industry. Keeping tabs on this market, India Pharma Outlook has shortlisted the select few companies in this field that have exhibited an unrelenting pursuit of excellence. By proving their dedication to fulfilling customer expectations and contributing to the market's evolution through their innovative disposition, these firms are blazing a trail. We look forward to receiving your feedback and suggestions. Sudhakar SinghEditoreditor@indiapharmaoutlook.comVol 2 · Issue 2 -12 · December, 2024Publisher Alok ChaturvediEditor Sudhakar SinghAssistant Editor Roshan AktharEditorial TeamViswanathan AThiruamuthan T K GM - Media & Graphic Designing VisualizerPrabhu DuttaSenior DesignerRajesh R BDesignerMadhusmita SahooAruna KAdvertising QueriesRahul KumarGM Sales & MarketingRavi kalgisales@indiapharmaoutlook.com Editorial Querieseditor@indiapharmaoutlook.comCirculation Manager Magendran PerumalMagazine Price is Rs. 150 per issuePrinted and Published By Alok Chaturvedi on behalf of Silicon Media Technologies Pvt. Ltd. and Printed at Precision Fototype Services at Sri Sabari Shopping Complex, 24 Residency Road Bangalore-560025 and Published At No. 124, 2nd Floor, Surya Chambers, Old Airport Road, Murugeshpalya, Bangalore-560017.Publisher Alok ChaturvediCopyright © 2024 Silicon Media Technologies Pvt. Ltd., All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher.Unlocking Growth through IP Protection
< Page 3 | Page 5 >